Publication | Open Access

Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice

Metabolically Dysfunctional MiceDysbiosisMedicineMicrobiotaGut MicrobiologyMetabolismMicrobiologyGut BarrierMetabolomicsIntestinal MicrobiotaPharmacologyMicrobiomePlasma Metabolome